id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-285130-tcnpskpy	Wang, Ke	The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China	2020-03-30		.txt	text/plain	2274	173	61	title: The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China Most of the critically ill patients received high-flow nasal cannula (HFNC) oxygen therapy. Among them, 27 (8.4%) patients experienced severe acute respiratory failure including 17 patients (63%) treated with HFNC as first-line therapy, 9 patients (33%) treated with noninvasive ventilation (NIV) and one patient (4%) treated with invasive ventilation. The NCIP patients who required HFNC, NIV or invasive ventilation to improve oxygen were classified as severe acute respiratory failure. In this study, 13% of patients experienced HFNC failure and required NIV as rescue therapy. Abbreviations NCIP: Novel coronavirus (2019-nCoV)-infected pneumonia; HFNC: High-flow nasal cannula; NIV: Noninvasive ventilation; ARDS: Acute respiratory distress syndrome; APACHE II: Acute physiology and chronic health evaluation II; SOFA: Sequential organ failure assessment; RR: Respiratory rate; HR: Heart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; IQR: Interquartile range.	./cache/cord-285130-tcnpskpy.txt	./txt/cord-285130-tcnpskpy.txt